R-Pharm (Russia)

Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis

Josef S Smolen, Eugen Feist, Saeed Fatenejad et al. · New England Journal of Medicine · 2022 · 70 citations · Full text

Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study

Evgeniy Nasonov, Saeed Fatenejad, Eugen Feist et al. · Annals of the Rheumatic Diseases · 2021 · 67 citations · Full text

Treatment of Idiopathic Recurrent Pericarditis With Goflikicept

V. Yu. Myachikova, А. L. Maslyanskiy, Oksana V. Vinogradova et al. · Journal of the American College of Cardiology · 2023 · 60 citations

Idiopathic Recurrent Pericarditis, Pericardial Disease, Constrictive Pericarditis +3

Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials

Hope S. Rugo, Henri Roché, Eva Thomas et al. · Clinical Breast Cancer · 2018 · 39 citations · Full text

Breast Oncology, Medicine, Pharmacology +7

Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study

Eugen Feist, Saeed Fatenejad, Sergey Grishin et al. · Annals of the Rheumatic Diseases · 2022 · 38 citations · Full text